Funding for this research was provided by:
David Telling Charitable Trust (72508)
Received: 11 December 2018
Accepted: 16 March 2020
First Online: 8 April 2020
Ethics approval and consent to participate
: Not applicable.
: AH is the Chief Investigator of ReMIT2, a pilot randomized controlled trial of sFlt-1/PlGF ratio in the management of women presenting with reduced fetal movements. He has no competing financial interests to declare.MG, LCC, and JZ have no competing interests to declare.DAL has received research support from Medtronic Ltd and Roche Diagnostics for research unrelated to this protocol or the planned systematic review.